治験サービスの世界市場

◆英語タイトル:Pharma Clinical Trial Services Market and Industry Forecast 2017-2027
◆商品コード:VGAIN7081160
◆発行会社(調査会社):visiongain
◆発行日:2017年7月
◆ページ数:188
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Sigle User(1名閲覧)GBP2,499 ⇒換算¥359,856見積依頼/購入/質問フォーム
Five UserGBP2,999 ⇒換算¥431,856見積依頼/購入/質問フォーム
Site License(全社内共有可)GBP4,999 ⇒換算¥719,856見積依頼/購入/質問フォーム
※visiongain社発行の調査レポートは、Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。

販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongain社の日本における正規販売代理店です。visiongain社の概要及び新刊レポートはこちらでご確認いただけます。
visiongain社が発行した当調査レポートでは、治験サービスの世界市場について調査・分析し、治験サービスの世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。
・レポートの概要
・イントロダクション
・治験サービスの世界市場
 (市場規模予測、市場動向、市場の成長要因・阻害要因など)
・治験サービスの世界市場:セグメント別市場分析
・治験サービスの世界市場:地域別市場分析、市場規模予測
・市場環境分析
・専門家の見解
・主要企業分析
・結論
【レポートの概要】

The pharma clinical trial services market is expected to grow at a CAGR of 9.5% in the first half of the forecast period. The market is expected to grow at a CAGR of 9.8% from 2016-2027. The pharma clinical trial services market is estimated at $39.56bn in 2016 dominated by the late-phase services, which held 56% of share.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 188-page report you will receive 145 charts – all unavailable elsewhere.

The 188-page report provides clear detailed insight into the pharma clinical trial services market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Pharma Clinical Trial Services Market forecasts from 2017-2027

• This report breaks down the revenue forecast for pharma clinical trial services market by type of service:
• Early Phase Services
• Late Phase Services
• Other Services

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW

• This report breaks down the revenue forecast for pharma clinical trial services market by End-Users:
• Pharma
• Biotech Companies
• Other End-Users

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW
• This report breaks down the revenue forecast for pharma clinical trial services market by Therapeutic Area:
• Cancer
• Cardiovascular
• CNS
• Infectious Diseases
• Metabolic Diseases
• Other Diseases

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
• North America: the US and Rest of North America
• Europe: France, Germany, the UK, Spain, Italy, Russia, Central and Eastern Europe, Rest of Europe
• Asia-Pacific: China, India, Japan, South Korea, Rest of APAC
• Rest of the World: Latin America, Middle East and Africa, Brazil

Each regional market is further divided by type of service, end-users and therapeutic area.

• Our study discusses factors that drive and restrain the pharma clinical trial services market. This report also provides a STEP analysis

• This report discusses the leading companies in pharma clinical trial services market:
• Quintiles IMS Holdings Inc.
• LabCorp (Covance Inc.)
• Pharmaceutical Product Development (PPD), LLC
• Parexel International Corporation
• ICON
• INC Research
• inVentiv Health
• PRA Health Sciences
• Chiltern International
• Charles River Laboratories

Visiongain’s study is intended for anyone requiring commercial analyses for the pharma clinical trial services market. You find data, trends and predictions.

Buy our report today Pharma Clinical Trial Services Market and Industry Forecast 2017-2027: Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-Users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases, Metabolic Diseases, Other Diseases.

【レポートの目次】

1. Report Overview
1.1 Global Pharma Clinical Trial Services Market Overview
1.2 Why You Should Read This Report
1.3 Key Questions Answered by This Analytical Report
1.4 Structure of the Report
1.5 Who is This Report For?
1.6 Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain

2. Pharma Clinical Trial Services Market Introduction
2.1 Clinical Trials: A Historical Perspective
2.2 Design and Execution of Clinical Trials
2.3 Phases of Clinical Trials
2.3.1 Phase I Trials: First In-Human Studies
2.3.2 Phase II Trials: Proof-of- Concept
2.3.3 Phase III Trials: Drug Approval Applications
2.3.4 Post-Marketing Studies
2.3.5 Key Elements of Clinical Trials
2.4 Common Trial Designs
2.4.1 Improving Clinical Trial Models through Adaptive Trial Designs
2.5 Clinical Trial Outsourcing
2.5.1 Challenges Exist in Conducting Clinical Trials
2.5.2 Benefits of Outsourcing

3. Pharma Clinical Trial Services: World Market by Services 2016-2027
3.1 The Impact of Economy on the Clinical Trial Services Market 2017-2027
3.2 Pharma Clinical Trial Services Market by Services 2017-2027
3.2.1 Early Phase Clinical Trial Services Market Forecasts 2017-2027
3.2.2 Late Phase Clinical Trial Services Market Forecasts 2017-2027
3.2.3 Other Clinical Trial Services Market Forecasts 2017-2027

4. Pharma Clinical Trial Services: World Market by End-Users 2016-2027
4.1 The Evolution of the Clinical Research Organizations (CROs)
4.2 Pharma Clinical Trial Services Market by End-Users 2017-2027
4.2.1 Clinical Trial Services Market by Pharma End-Users Forecasts 2017-2027
4.2.2 Clinical Trial Services Market by Biotech Companies End-Users Forecasts 2017-2027
4.2.3 Clinical Trial Services Market by Other End-Users Forecasts 2017-2027

5. Pharma Clinical Trial Services: World Market by Therapeutic Areas 2017-2027
5.1 Rise of Clinical Trial Services in Key Therapeutic Areas
5.1.1 Cancer Clinical Trial Services Market Forecasts 2017-2027
5.1.2 Cardiovascular Diseases Clinical Trial Services Market Forecasts 2017-2027
5.1.3 CNS Diseases Clinical Trial Services Market Forecasts 2017-2027
5.1.4 Infectious Diseases Clinical Trial Services Market Forecasts 2017-2027
5.1.5 Metabolic Diseases Clinical Trial Services Market Forecasts 2017-2027
5.1.6 Other Diseases Clinical Trial Services Market Forecasts 2017-2027

6. Regional Pharma Clinical Trial Services Market Forecasts 2017-2027
6.1 North American Pharma Clinical Trial Services Market Forecasts 2017-2027
6.1.1 U.S. Pharma Clinical Trial Services Market Forecasts 2017-2027
6.1.2 Rest of North America Pharma Clinical Trial Services Market Forecasts 2017-2027
6.2 North American Pharma Clinical Trial Services Market Forecasts by Service 2017-2027
6.3 North American Pharma Clinical Trial Services Market Forecasts by Therapeutic Area 2017-2027
6.4 North American Pharma Clinical Trial Services Market Forecasts by End-Users 2017-2027
6.5 Europe Pharma Clinical Trial Services Market Forecasts 2017-2027
6.5.1 France Pharma Clinical Trial Services Market Forecasts 2017-2027
6.5.2 Germany Pharma Clinical Trial Services Market Forecasts 2017-2027
6.5.3 U.K. Pharma Clinical Trial Services Market Forecasts 2017-2027
6.5.4 Spain Pharma Clinical Trial Services Market Forecasts 2017-2027
6.5.5 Italy Pharma Clinical Trial Services Market Forecasts 2017-2027
6.5.6 Russia Pharma Clinical Trial Services Market Forecasts 2017-2027
6.5.7 Central and Eastern Europe Pharma Clinical Trial Services Market Forecasts 2017-2027
6.5.8 Rest of Europe Pharma Clinical Trial Services Market Forecasts 2017-2027
6.6 European Pharma Clinical Trial Services Market Forecasts by Service 2017-2027
6.7 European Pharma Clinical Trial Services Market Forecasts by Therapeutic Area 2017-2027
6.8 European Pharma Clinical Trial Services Market Forecasts by End-Users 2017-2027
6.9 Asia-Pacific Pharma Clinical Trial Services Market Forecasts 2017-2027
6.9.1 China Pharma Clinical Trial Services Market Forecasts 2017-2027
6.9.2 India Pharma Clinical Trial Services Market Forecasts 2017-2027
6.9.3 Japan Pharma Clinical Trial Services Market Forecasts 2017-2027
6.9.4 South Korea Pharma Clinical Trial Services Market Forecasts 2017-2027
6.9.5 Rest of Asia-Pacific (APAC) Pharma Clinical Trial Services Market Forecasts 2017-2027
6.10 Asia-Pacific Pharma Clinical Trial Services Market Forecasts by Service 2017-2027
6.11 Asia-Pacific Pharma Clinical Trial Services Market Forecasts by Therapeutic Area 2017-2027
6.12 Asia-Pacific Pharma Clinical Trial Services Market Forecasts by End-Users 2017-2027
6.13 Rest of the World (RoW) Pharma Clinical Trial Services Market Forecasts 2017-2027
6.13.1 Latin America Pharma Clinical Trial Services Market Forecasts 2017-2027
6.13.2 Middle East and Africa Pharma Clinical Trial Services Market Forecasts 2017-2027
6.13.3 Brazil Pharma Clinical Trial Services Market Forecasts 2017-2027
6.14 Rest of the World (RoW) Pharma Clinical Trial Services Market Forecasts by Service 2017-2027
6.15 Rest of the World (RoW) Pharma Clinical Trial Services Market Forecasts by Therapeutic Area 2017-2027
6.16 Rest of the World (RoW) Pharma Clinical Trial Services Market Forecasts by End-Users 2017-2027

7. Drivers & Restraints
7.1 Drivers and Restraints 2017-2027
7.2 Drivers
7.2.1 Increased research and development by biopharmaceutical companies leading to better utilization of clinical trial services
7.2.2 Contract research organizations present in the emerging markets to gain major foothold in the forecast period
7.2.3 Growth of biopharma R&D expenditures will lead to increase in the clinical trial market
7.2.4 Emerging markets especially China becoming a much sought-after clinical trial destination
7.2.5 Increased Strategic Alliances among Large BioPharma Companies and CROs benefitting the market
7.3 Restraints
7.3.1 Regulatory Constraints such as longer approval time for clinical trials
7.3.2 Poor Physician and Nurse Engagement Leading to Low Patient Recruitment Rates

8. Leading Companies in the Pharma Clinical Trial Services Market
8.1 Quintiles IMS Holdings Inc.
8.1.1 Quintiles IMS Holdings Inc. Business Overview
8.1.2 Quintiles IMS Holdings Inc. Financial Overview
8.1.3 Quintiles IMS Holdings Inc. Corporate Strategy
8.2 LabCorp (Covance Inc.)
8.2.1 LabCorp Business Overview
8.2.2 LabCorp Financial Overview
8.2.3 LabCorp (Covance Inc.) Corporate Strategy
8.3 Pharmaceutical Product Development (PPD), LLC
8.3.1 Pharmaceutical Product Development (PPD) Business Overview
8.3.2 Pharmaceutical Product Development (PPD) Financial Overview
8.3.3 Pharmaceutical Product Development (PPD) Corporate Strategy
8.4 Parexel International Corporation
8.4.1 Parexel International Corporation Business Overview
8.4.2 Parexel International Corporation Financial Overview
8.4.3 Parexel International Corporation Corporate Strategy
8.5 ICON
8.5.1 ICON Business Overview
8.5.2 ICON Financial Overview
8.5.3 ICON Corporate Strategy
8.6 INC Research
8.6.1 INC Research Business Overview
8.6.2 INC Research Financial Overview
8.6.3 INC Research Corporate Strategy
8.7 inVentiv Health
8.7.1 inVentiv Health Business Overview
8.7.2 inVentiv Health Financial Overview
8.7.3 inVentiv Health Corporate Strategy
8.8 PRA Health Sciences
8.8.1 PRA Health Sciences Business Overview
8.8.2 PRA Health Sciences Financial Overview
8.8.3 PRA Health Sciences Corporate Strategy
8.9 Chiltern International
8.9.1 Chiltern International Business Overview
8.9.2 Chiltern International Financial Overview
8.9.3 Chiltern International Corporate Strategy
8.10 Charles River Laboratories
8.10.1 Charles River Laboratories Business Overview
8.10.2 Charles River Laboratories Financial Overview
8.10.3 Charles River Laboratories Corporate Strategy

9. STEP Analysis of the Pharma Clinical Trial Services Market 2017-2027
9.1 STEP Analysis of the Pharma Clinical Trial Services Market
9.2 Social Factors Affecting Clinical Trials
9.2.1 Ethical Considerations in Conducting Clinical Trials
9.2.2 Patient Recruitment: Major Challenge in Developed Markets
9.3 Technological Development for Improved Trials
9.3.1 Electronic Data Capture
9.3.2 eClinical Trial Tools
9.3.3 Use of Electronic Health Records for Faster Patient Recruitment
9.3.4 Cloud Computing used as a Tool for Multicentre Trials
9.4 Economic Considerations for Clinical Trial Outsourcing
9.4.1 Pharma is adjusting its R&D strategies
9.4.2 CROs tend to be attractive for Private Investigators
9.5 Political and Regulatory Considerations for Clinical Trial Outsourcing
9.5.1 Drug Safety and Clinical Trials Post-Approval
9.5.2 Cutting Red Tape and Other Regulatory Developments

10. Conclusions
10.1 Current Leading Pharma Clinical Trial Services Market Segments
10.1.1 Leading Contract Research Organizations
10.1.2 Leading Regional Markets
10.1.3 Emerging Pharma Clinical Trial Services Markets

Appendices
Glossary
Visiongain Report Sales Order Form
About Visiongain
Visiongain report evaluation form

List of Tables
Table 2.1 Founding Members of the ICH
Table 2.2 Types of Adaptive Trial Design
Table 3.1 Breakdown of Pharma Clinical Spending by Phase, 2014
Table 3.2 Breakdown of Pharma Clinical Trial Services by Services
Table 3.3 Table 3.3 Pharma Clinical Trial Services Market by Services: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 3.4 Table 3.4 Early Phase Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 3.5 Table 3.5 Late Phase Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%) 2016-2027
Table 3.6 Other Pharma Clinical Trial Services Markets by Region: Forecast ($bn, AGR%, CAGR%) 2016-2027
Table 4.1 Pharma Clinical Trial Services Submarket by End-Users: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 4.2 Clinical Trial Services Pharma Submarket by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 4.3 Clinical Trial Services Biotech Companies Submarket by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 4.4 Clinical Trial Services Other End-Users Submarket by Region: Forecasts ($bn, AGR%, CAGR%), 2016-2027
Table 5.1 Pharma Clinical Trial Services Submarkets by Therapeutic Area: Forecast ($bn, AGR %, CAGR%), 2016-2027
Table 5.2 Cancer Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 5.3 Cardiovascular Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 5.4 CNS Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 5.5 Infectious Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 5.6 Metabolic Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 5.7 Other Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 6.1 Regional Pharma Clinical Trial Services Market: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.2 U.S. Pharma Clinical Trial Services Market: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.3 Rest of North America Pharma Clinical Trial Services Market: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.4 North American Pharma Clinical Trial Services Market by Service: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.5 North American Pharma Clinical Trial Services Market by Therapeutic Area: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.6 North American Pharma Clinical Trial Services Market by End-Users: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.7 France Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.8 Germany Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.9 U.K. Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.10 Spain Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.11 Italy Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.12 Russia Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.13 Central and Eastern Europe (CEE) Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.14 Rest of Europe Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.15 European Pharma Clinical Trial Services Market by Service: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.16 European Pharma Clinical Trial Services Market by Therapeutic Area: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.17 European Pharma Clinical Trial Services Market by End-Users: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.18 China Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.19 India Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.20 Japan Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.21 South Korea Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.22 Rest of Asia-Pacific (APAC) Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.23 Asia-Pacific Pharma Clinical Trial Services Market by Service: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.24 Asia-Pacific Pharma Clinical Trial Services Market Forecasts by Therapeutic Area: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.25 Asia-Pacific Pharma Clinical Trial Services Market by End-Users: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.26 Latin America Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.27 Middle East and Africa Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.28 Brazil Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.29 RoW Pharma Clinical Trial Services Market Forecasts by Service: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.30 RoW Pharma Clinical Trial Services Market by Therapeutic Area: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.31 RoW Pharma Clinical Trial Services Market by End-Users: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 9.1 STEP Analysis of Pharma Clinical Trial Services Market 2016-2027

List of Figures
Figure 2.1 Brief History of Clinical Trials
Figure 3.1 Breakdown of Pharma Clinical Spending by Phase
Figure 3.2 Global Pharma Clinical Trial Services Market by Services: (% Share), 2016
Figure 3.3 Pharma Clinical Trial Services Market by Services: Revenue ($bn), 2016-2027
Figure 3.4 Early Phase Services Market Forecasts: AGR (%), 2017-2027
Figure 3.5 Global Early Phase Clinical Trial Services Market by Region: Revenue ($bn), 2016-2027
Figure 3.6 Global Early Phase Clinical Trial Services Market Share by Region: (% Share), 2016-2027
Figure 3.7 Late Phase Clinical Trial Services Market Forecasts: AGR (%), 2017-2027
Figure 3.8 Global Late Phase Clinical Trial Services Market by Region: Revenue ($bn), 2016-2027
Figure 3.9 Global Late Phase Clinical Trial Services by Region: (% Share), 2016-2027
Figure 3.10 Other Pharma Clinical Trial Services Submarket Forecasts: AGR (%), 2017-2027
Figure 3.11 Global Other Pharma Clinical Trial Services Market by Region: Revenue ($bn), 2016-2027
Figure 3.12 Global Other Pharma Clinical Trial Services by Region: (% Share), 2016-2027
Figure 4.1 Pharma Clinical Trial Services Submarkets by End-Users: Revenue ($bn), 2016-2027
Figure 4.2 Clinical Trial Services Pharma Submarket: AGR (%), 2017-2027
Figure 4.3 Global Clinical Trial Services Pharma Submarket by Region: Revenue ($bn), 2016-2027
Figure 4.4 Global Clinical Trial Services Pharma Submarket by Region: (% Share), 2016-2027
Figure 4.5 Clinical Trial Services Biotech Companies Submarket: AGR (%), 2017-2027
Figure 4.6 Global Clinical Trial Services Biotech Companies Submarket by Region: Revenue ($bn), 2016-2027
Figure 4.7 Global Clinical Trial Services Biotech Companies Submarket by Region: (% Share), 2016-2027
Figure 4.8 Clinical Trial Services Other End-Users Submarket: AGR (%), 2017-2027
Figure 4.9 Global Clinical Trial Services Other End-Users Submarket by Region: Revenue ($bn), 2016-2027
Figure 4.10 Global Clinical Trial Services Other End-Users Submarket by Region: (% Share), 2016-2027
Figure 5.1 Global Pharma Clinical Trial Services Market by Therapeutic Area: (% Share), 2016
Figure 5.2 Pharma Clinical Trial Services Submarkets by Therapeutic Area: Revenue ($bn), 2016-2027
Figure 5.3 Cancer Clinical Trial Services Submarket: AGR (%), 2017-2027
Figure 5.4 Global Cancer Clinical Trial Services Submarket by Region: Revenue ($bn), 2016-2027
Figure 5.5 Global Cancer Clinical Trial Services Submarket by Region: (% Share), 2016-2027
Figure 5.6 Cardiovascular Diseases Clinical Trial Services Submarket: AGR (%), 2017-2027
Figure 5.7 Global Cardiovascular Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2016-2027
Figure 5.8 Global Cardiovascular Diseases Clinical Trial Services Submarket by Region: (% Share), 2016-2027
Figure 5.9 CNS Diseases Clinical Trial Services Submarket: AGR (%), 2017-2027
Figure 5.10 Global CNS Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2016-2027
Figure 5.11 Global CNS Diseases Clinical Trial Services Submarket by Region: (% Share), 2016-2027
Figure 5.12 Infectious Diseases Clinical Trial Services Submarkets: AGR (%), 2017-2027
Figure 5.13 Global Infectious Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2016-2027
Figure 5.14 Global Infectious Diseases Clinical Trial Services Submarket by Region: (% Share), 2016-2027
Figure 5.15 Metabolic Diseases Clinical Trial Services Submarkets: AGR (%), 2017-2027
Figure 5.16 Global Metabolic Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2016-2027
Figure 5.17 Global Metabolic Diseases Clinical Trial Services Submarket by Region: (% Share), 2016-2027
Figure 5.18 Other Diseases Clinical Trial Services Submarket: AGR (%), 2017-2027
Figure 5.19 Global Other Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2016-2027
Figure 5.20 Global Other Diseases Clinical Trial Services Submarket by Region: (% Share), 2016-2027
Figure 6.1 Regional Pharma Clinical Trial Services Markets: Revenue ($bn), 2017-2027
Figure 6.2 North American Pharma Clinical Trial Services by Country: (% Share), 2016
Figure 6.3 U.S. Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.4 Rest of North America Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.5 North American Pharma Clinical Trial Services Market by Service: Revenue ($bn), 2016-2027
Figure 6.6 North American Pharma Clinical Trial Services Market by Therapeutic Area: Revenue ($bn), 2016-2027
Figure 6.7 North American Pharma Clinical Trial Services Market by End-Users: Revenue ($bn), 2016-2027
Figure 6.8 European Pharma Clinical Trial Services by Country: (% Share), 2016
Figure 6.9 France Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.10 Germany Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.11 U.K. Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.12 Spain Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.13 Italy Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.14 Russia Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.15 Central and Eastern Europe (CEE) Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.16 Rest of Europe Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.17 European Pharma Clinical Trial Services Market by Service: Revenue ($bn), 2016-2027
Figure 6.18 European Pharma Clinical Trial Services Market by Therapeutic Area: Revenue ($bn), 2016-2027
Figure 6.19 European Pharma Clinical Trial Services Market by End-users: Revenue ($bn), 2016-2027
Figure 6.20 Asia-Pacific Pharma Clinical Trial Services Market Share by Country: (% Share), 2016
Figure 6.21 China Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.22 India Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.23 Japan Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.24 South Korea Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.25 Rest of Asia-Pacific (APAC) Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.26 Asia-Pacific Pharma Clinical Trial Services Market Revenue by Service: Revenue ($bn), 2016-2027
Figure 6.27 Asia-Pacific Pharma Clinical Trial Services Market by Therapeutic Area: Revenue ($bn), 2016-2027
Figure 6.28 Asia-Pacific Pharma Clinical Trial Services Market by End-Users: Revenue ($bn), 2016-2027
Figure 6.29 Rest of the World (RoW) Pharma Clinical Trial Services Market by Country (% Share), 2016
Figure 6.30 Latin America Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.31 Middle East and Africa Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.32 Brazil Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.33 RoW Pharma Clinical Trial Services Market by Service: Revenue ($bn), 2016-2027
Figure 6.34 RoW Pharma Clinical Trial Services Market by Therapeutic Area: Revenue ($bn), 2016-2027
Figure 6.35 RoW Pharma Clinical Trial Services Market Revenue by End-Users: Revenue ($bn), 2016-2027
Figure 7.1 Market: Drivers and Restraints, 2017-2027
Figure 8.1 Quintiles IMS Holdings Inc. 2016 Annual Revenue by Business Segment: (% Share)
Figure 8.2 LabCorp (Covance Inc.) 2016 Annual Revenue by Business Segments: (% Share)
Figure 8.3 LabCorp Annual Revenue 2012-2016 ($bn)
Figure 8.4 Pharmaceutical Product Development (PPD) 2010 Annual Revenue by Business Segment (% Share)
Figure 8.5 Parexel International Corporation 2016 Annual Revenue by Business Segment (% Share)
Figure 8.6 Parexel International Corporation Annual Revenue 2012- 2016 ($mn)
Figure 8.7 ICON Annual Revenue 2012- 2016 ($bn)
Figure 8.8 INC Research 2016 Annual Revenue by Business Segment: (% Share)
Figure 8.9 INC Research Annual Revenue 2012-2016 ($bn)
Figure 8.10 PRA Health Sciences 2016 Annual Revenue by Business Segment: (% Share)
Figure 8.11 PRA Health Sciences Annual Revenue 2012-2016 ($bn)
Figure 8.12 Charles River Laboratories 2016 Annual Revenue by Business Segment: (% Share)
Figure 8.13 Charles River Laboratories Annual Revenue 2012-2016 ($bn)
Figure 10.1 Global Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 10.2 Pharma Clinical Trial Services Market by Region: Revenue ($bn), 2016-2027

【レポートのキーワード】

治験サービス

★調査レポート[治験サービスの世界市場]販売に関する免責事項
★調査レポート[治験サービスの世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆